Impact of Neurological Diseases on the Prognosis of Bullous Pemphigoid: A Retrospective Study of 178 Patients
NCT03320798 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 178
Last updated 2017-10-25
Summary
Bullous pemphigoid affects mainly elderly patients. It is often associated with neurologic disorders, which represent a major risk factor of the disease
Conditions
- Bullous Pemphigoid
Interventions
- OTHER
-
Data record
Sponsors & Collaborators
-
CHU de Reims
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-10-01
- Primary Completion
- 2014-10-01
- Completion
- 2015-03-01
Countries
- France
Study Locations
More Related Trials
-
Immunotherapy and Paraneoplastic Neurological Syndromes
NCT02343211 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Diagnostic Contributions of Nerve Ultrasound in Chronic Inflammatory Demyelinating Polyneuropathy Associating Systemic Diseases (CIDP Echo-nerf)
NCT05257733 ·Status: WITHDRAWN
-
Neuropathy and Anti-GFAP Antibodies
NCT05742087 ·Status: UNKNOWN
-
Predictive Factors of Long Term Outcome in MMN
NCT04015934 ·Status: COMPLETED
-
Collection of Biological Samples From Patients With Rare Neurological Diseases
NCT04698421 ·Status: RECRUITING
-
RIMAG Study: Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy
NCT00259974 ·Status: COMPLETED ·Phase: PHASE3
-
The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies
NCT03864185 ·Status: COMPLETED ·Phase: PHASE2
-
Immediate Versus Delayed Treatment With Azathioprine or Rituximab in Anti-MOG Antibodies Associated Acute Demyelinating Syndromes in Children: a Randomized Controlled Clinical Trial
NCT05545384 ·Status: RECRUITING ·Phase: PHASE3
-
InertiaLocoGraphy as a Biomarker of Immunoglobulin Therapy Efficacy in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NCT04529291 ·Status: WITHDRAWN ·Phase: NA
-
Longitudinal Analysis And Sample Collection To Evaluate PML Risk Host Markers for PML Risk Host Markers for PML Risk
NCT02440126 ·Status: COMPLETED
-
Immune Abnormalities in Sporadic Inclusion Body Myositis
NCT00030212 ·Status: COMPLETED
-
Study of the Efficacy and Safety for Rituximab in Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
NCT06952413 ·Status: RECRUITING ·Phase: PHASE2
-
Study of STIM1 Membrane Expression
NCT04978948 ·Status: RECRUITING
-
Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NCT02629796 ·Status: COMPLETED
-
Rituximab to Treat Neuropathy With Anti-MAG Antibodies
NCT00050245 ·Status: COMPLETED ·Phase: PHASE2
-
Study of CIDP Patients During IVIG Treatment
NCT00305266 ·Status: COMPLETED
-
Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis
NCT01813617 ·Status: COMPLETED
-
RWE-based Treatment Patterns and Outcomes in CIDP
NCT05940922 ·Status: UNKNOWN
-
A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NCT03861481 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety Study of GAMMAGARD LIQUID (GGL) in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
NCT05363358 ·Status: COMPLETED
-
EVALUATION OF SERUM INFLAMMATORY CYTOKINE CONCENTRATION IN HEREDITARY SENSITIVOMOTOR NEUROPATHIES
NCT06808581 ·Status: COMPLETED ·Phase: NA
-
Transcriptome Analysis of the Peripheral Blood in CIDP
NCT02404298 ·Status: UNKNOWN ·Phase: NA
-
Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin
NCT02892890 ·Status: COMPLETED ·Phase: NA
-
Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy
NCT07121985 ·Status: NOT_YET_RECRUITING
-
A Study of CDX-0159 in Patients With Prurigo Nodularis
NCT04944862 ·Status: COMPLETED ·Phase: PHASE1